GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

10368	Companies
216016	Keywords
145738	Articles
114389	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 07/26/2024 at 13:45, 1 year 9 months ago

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
GENFIT receives positive opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis, awaiting final European Commission decision. Details in press release

GENFIT PBC Treatment Positive Opinion EMA Committee Ipsen's Iqirvo
PRESS RELEASE

published on 07/26/2024 at 13:45, 1 year 9 months ago

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive
Avis positif du CHMP pour l’Iqirvo® d’Ipsen dans la Cholangite Biliaire Primitive. GENFIT annonce l'avis favorable de l'EMA pour le traitement de la CBP avec élafibranor. Décision finale de l'UE en 2024

Cholangite Biliaire Primitive GENFIT CHMP Iqirvo Elafibranor
BRIEF

published on 07/09/2024 at 22:15, 1 year 9 months ago

GENFIT Announces Half-Year Liquidity Contract Report with Crédit Industriel et Commercial

Liquidity Contract Shares Biopharmaceutical GENFIT Trading Report
BRIEF

published on 07/09/2024 at 22:15, 1 year 9 months ago

GENFIT annonce son rapport semestriel sur les contrats de liquidité avec le Crédit Industriel et Commercial

Contrat De Liquidité Actions Biopharmaceutique GENFIT Rapport De Négociation
PRESS RELEASE

published on 07/09/2024 at 22:10, 1 year 9 months ago

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, revealing trading details and resources as of June 30, 2024

Liquidity Contract Crédit Industriel Et Commercial GENFIT Resources Trading Details
PRESS RELEASE

published on 07/09/2024 at 22:10, 1 year 9 months ago

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
GENFIT annonce le bilan semestriel du contrat de liquidité avec le Crédit Industriel et Commercial, comprenant les moyens et transactions réalisés. Analyse détaillée

Bilan Semestriel Transactions Liquidité GENFIT Société Biopharmaceutique
BRIEF

published on 06/17/2024 at 22:15, 1 year 10 months ago

GENFIT: NIS2+® Included in New Clinical Guidelines for MASLD

GENFIT MASH NIS2+® MASLD Clinical Guidelines
BRIEF

published on 06/17/2024 at 22:15, 1 year 10 months ago

GENFIT : NIS2+® inclus dans les nouvelles directives cliniques pour le MASLD

GENFIT PURÉE NIS2+® MASLD Lignes Directrices Cliniques
PRESS RELEASE

published on 06/17/2024 at 22:10, 1 year 10 months ago

GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
GENFIT announces inclusion of NIS2+® in new EASL-EASD-EASO Clinical Practice Guidelines for MASLD, as a key tool for detecting at-risk MASH. Guidelines provide update on prevention, screening, diagnosis, follow-up, and treatment for MASLD

GENFIT MASH NIS2+® MASLD EASL-EASD-EASO
PRESS RELEASE

published on 06/17/2024 at 22:10, 1 year 10 months ago

GENFIT : Les nouvelles recommandations de pratique clinique de l'EASL-EASD-EASO pour la MASLD incluent NIS2+® comme outil-clé pour la détection de la MASH à risque
Les nouvelles recommandations de l'EASL-EASD-EASO incluent NIS2+® comme outil-clé pour la détection de la MASH à risque. GENFIT annonce son rôle dans l'identification des patients pour les traitements émergents de la MASH

GENFIT NIS2+® Recommandations Cliniques Détection De La MASH Maladies Rares Du Foie

Accesswire

Published on 05/08/2026 at 01:50, 6 hours 38 minutes ago

Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 7 hours 43 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 8 hours 28 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 8 hours 58 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 9 hours 13 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting

View all ACCESSWIRE

EQS Group

Published on 05/08/2026 at 08:02, 26 minutes ago

Commerzbank delivers strong first quarter and targets Net RoTE of 21% by 2030
Published on 05/08/2026 at 08:00, 27 minutes ago

LIBERO to attend the World Football Summit in Madrid
Published on 05/08/2026 at 07:58, 30 minutes ago

Commerzbank delivers strong first quarter and targets Net RoTE of 21% by 2030
Published on 05/08/2026 at 07:55, 33 minutes ago

AUSTRIAN POST IN Q1 2026: Slight first-quarter revenue improvement despite a challenging market environment, earnings below the previous year as expected
Published on 05/08/2026 at 07:30, 58 minutes ago

Bechtle achieves double-digit growth in business volume and earnings

Les Echos

Published on 05/07/2026 at 19:15, 13 hours 13 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 13 hours 13 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 13 hours 22 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 13 hours 22 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 13 hours 28 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE